SEPTInvestingStart Free
Stocks/JAGX/SEC Filings/10-Q Nov 16, 2026

JAGX 10-Q: SEC filing

Jaguar Health, Inc.

Filed with the SEC on Nov 16, 2026 · accession 0001193125-26-461940

JAGX filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

Jaguar Health, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and disclosing various financing arrangements, including preferred stock issuances, warrants, and notes with Streeterville Capital and Iliad Capital.

For details, click here →How to read a 10-Q →

Key details

Financing counterpartyStreeterville Capital, LLC
Financing counterpartyIliad Capital Limited

✦ Ask GOAX AI about this filing — what it means for JAGX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for JAGX?

Click here

Frequently asked questions

What did JAGX file with the SEC on Nov 16, 2026?

JAGX filed a 10-Q (SEC filing). Jaguar Health, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and disclosing various financing arrangements, including preferred stock issuances, warrants, and notes with Streeterville Capital and Iliad Capital.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other JAGX SEC filings

  • 424B3 · Shelf registrationNov 9, 2026
  • 8-K · Stock splitNov 6, 2026
  • EFFECT · SEC filingNov 5, 2026
  • 8-K · Dividend changeNov 3, 2026
  • S-3 · Shelf registrationNov 3, 2026
  • 8-K · SEC filingOct 28, 2026
  • S-3 · Shelf registrationOct 22, 2026
  • DEF 14A · Stock splitOct 8, 2026
  • 8-K · Material agreementOct 5, 2026
  • 8-K · Material agreementSep 28, 2026

Get alerts when JAGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
JAGX overviewJAGX analysisJAGX newsLatest SEC filings
Source: SEC EDGAR filing 0001193125-26-461940. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.